Literatur
- 1
Barbieri R L.
Hormone treatment of endometriosis: the estrogen threshold hypothesis.
Am J Obstet Gynecol.
1992;
166
740-745
- 2
Elkind-Hirsch K E, Anania C, Mack M, Malinak R.
Combination gonadotrophin-releasing hormone agonist and oral contraceptive therapy
improves treatment of hirsute women with ovarian hyperandrogenism.
Fertil Steril.
1995;
63
970-978
- 3
Finkelstein J S, Klibanski A, Schaefer E H. et al .
Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency.
N Engl J Med.
1994;
331
1618-1623
- 4
Freundl G, Gödtke K, Gnoth C, Godehardt E, Kienle E.
Steroidal “add-back” therapy in patients treated with GnRH agonists.
Gynecol Obstet Invest.
1998;
45 (Suppl 1)
22-30
- 5
Hornstein M D, Surrey E S, Weisberg G W, Casino L A.
Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study.
Obstet Gynecol.
1998;
91
16-24
- 6
Howell R, Crook D, Edmonds D K, Lees B, Dowsett M, Stevenson J.
Gonadotrophin-releasing hormone analogue (goserelin) plus hormone replacement therapy
for the treatment of endometriosis: a randomised control trial.
Fertil Steril.
1995;
64
474-481
- 7
Kiesel L, Bertges K, von Holst T R, Runnebaum B.
Treatment of endometriosis.
Arch Gynecol Obstet.
1989;
245
937-940
- 8
Kiilholma P, Tuimala R, Kivinen S, Korhonen M, Hagman E.
Comparison of the gonadotrophin-releasing hormone agonist goserelin acetate alone
versus goserelin combined with estrogen-progestogen add-back therapy in the treatment
of endometriosis.
Fertil Steril.
1995;
64
903-908
- 9
Lemay A, Maheux R, Huot C, Blanchet J, Faure N.
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist
inhibition of ovarian function in the treatment of endometriosis.
Am J Obstet Gynecol.
1988;
158
233-236
- 10
Lemay A, Faure N.
Sequential estrogen-pogestin adition to gonadotrophin-releasing hormone agonist suppression
for the chronic treatment of ovarian hyperandrogenism: a pilot study.
J Clin Endocrinol Metab.
1994;
79
1716-1722
- 11
Lindsay P C, Shaw R W, Bennink H J, Kicovic P.
The effect of add-back treatment with tibolone (livial) on patients treated with
the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
Fertil Steril.
1996;
65
342-348
- 12
Luciano A A, Turksoy R N, Carleo J.
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis.
Obstet Gynecol.
1988;
72
323-327
- 13
Maheux R, Lemay A.
Treatment of peri-menopausal women: potential long-term therapy with a depot GnRH
agonist combined with hormone replacement therapy.
Br J Obstet Gynaecol.
1992;
99 (Suppl 7)
13-17
- 14
Makarainen L, Ronneberg L, Kauppila A.
Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects
of gonadotopin-releasing hormone agonist without changing its efficacy in endometriosis.
Fertil Steril.
1996;
65
29-34
- 15
Moghissi K S.
Add-back therapy in the treatment of endometriosis: the North American experience.
Br J Obstet Gynaecol.
1996;
103 (Suppl 14)
14
- 16
Naor Z, Shacham S, Harris D, Seger R, Reiss N.
Signal transduction of the gonadotropin releasing hormone (GnRH) receptor: cross
talk of calcium, proteinkinase C (PKC) and arachidonic acid.
Cell Molec Neurobiol.
1996;
15
527-544
- 17
Prentice A, Deary A J, Goldbeck-Wood S, Farquhar C, Smith S K.
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis.
Cochrane Database Sys Rev.
2000;
2
CD000346
- 18
Rock J A, Truglia J A, Caplan R J.
Zoladex Endometriosis Study Group: Zoladex (goserelin acetate implant) in the treatment
of endometriosis: a randomized comparison with danazol.
Obstet Gynecol.
1993;
82
198-205
- 19
Rody A, Kissler S, Greb R R, Kaufmann M, Kiesel L.
Der klinische Einsatz von GnRH- Analoga in der Gynäkologie.
Geburth Frauenheilk.
2003;
63
R41-R64
- 20
Roland M, Leistein D, Kane R.
Endometriosis therapy with medroxyprogesterone acetate.
J Reprod Med.
1976;
17
249-252
- 21
Roux C, Pellissier C, Listrat V. et al .
Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal
calcitonin.
Osteoporosis Int.
1995;
5
185-190
- 22
Surrey E S, Judd H L.
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone
and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis:
a prospective randomized trial.
J Clin Endocrinol Metab.
1992;
75
558-563
- 23
Surrey E S, Voigt B, Fournet N, Judd H L.
Prolonged gonadotrophin-releasing hormone agonist treatment of symptomatic endometriosis:
the role of cyclic sodium etidronate and low-dose norethindrone add-back therapy.
Fertil Steril.
1995;
63
747-755
- 24
Surrey E S, Hornstein M D, Weisberg G. et al .
The efficacy of norethindorne acetate and conjugated equine estrogens combined with
a gonadotropin releasing hormone agonist in the management of symptomatic endometriosis:
a one-year multicenter trial.
J Soc Gynecol Investig.
1997;
4
121A
- 25
Surrey E S, Hornstein M D.
Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term
follow-up.
Obstet Gynecol.
2002;
99
709-719
- 26
Tanaka T.
Effects of herbal medicines on menopausal symptoms induced by gonadotropin-releasing
hormone agonist therapy.
Clin Exp Obstet & Gyn.
2001;
1
20-23
- 27
Taskin O, Yalcinoglu A I, Kukuk S. et al .
Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment
in patients with endometriosis.
Fertil Steril.
1997;
67
40-45
- 28
Thomas E J, Okuda K J, Thomas N M.
The combination of depot gonadotrophin releasing hormone agonist and cyclical hormone
replacement therapy for dysfunctional uterine bleeding.
Br J Obstet Gynaecol.
1991;
98
1155-1159
- 29
Valimaki M, Nilsson C G, Roine R, Ylikorkala O.
Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins
in patients with endometriosis.
J Clin Endocrinol Metab.
1989;
69
1097-1103
- 30
Wheeler J M, Knittle J D, Miller J D.
Lupron Endometriosis Study Group: Depot leuprolide acetate versus danazol in the
treatment of women with symptomatic endometriosis: a multicenter double-blind randomized
clinical trial. I. Efficacy results.
Am J Obstet Gynecol.
1992;
167
1367-1371
- 31
Wheeler J M, Knittle J D, Miller J D.
Lupron Endometriosis Study Group: Depot leuprolide acetate versus danazol in the
treatment of women with symptomatic endometriosis: a multicenter double-blind randomized
clinical trial. II. Assessment of safety.
Am J Obstet Gynecol.
1993;
169
26-33
Prof. Dr. med. Liselotte Mettler
Michaelis-Str. 16
24105 Kiel
